Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy.
Fosinopril sodium, a phosphinic acid derivative is an angiotensin converting enzyme (ACE) inhibitor, which had been employed for the treatment of hypertension and congestive heart failure; long tem use of ACE inhibitor often result in stress ulcers due to which H(2) receptor antagonists are also concurrently prescribed. The later compete with histamine for H(2) receptors and block gastric acid secretion and some cardiovascular effects of histamine. Our studies are focused on the in vitro availability of fosinopril in presence of commonly used H(2) receptor antagonists. Derivative spectroscopy has been employed for the quantitation of fosinopril and H(2) receptor antagonists followed by linear regression analysis. These studies were carried out in buffers of pH 7.4 and 9 at 37, 48 and 60( masculine)C. Stability constant and thermodynamic function had also been calculated in order to evaluate the reaction mechanism. Commonly prescribed H(2) receptor antagonists like cimetidine, ranitidine and famotidine were used in these studies. Present study clearly indicated that most of the H(2) receptor antagonists studied decreased the availability of fosinopril which conclude that availability of fosinopril can be affected by the concurrent administration of H(2) receptor antagonists.
Sultana
Najma
N
Research Institute of Pharmaceutical Sciences, University of Karachi, Karachi-75270, Pakistan.
Arayne
M Saeed
MS
Sana
Aisha
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D002021:Buffers; D002927:Cimetidine / Q000737:chemistry; D004347:Drug Interactions; D015738:Famotidine / Q000737:chemistry; D017328:Fosinopril / Q000737:chemistry* / Q000494:pharmacology; D006635:Histamine H2 Antagonists / Q000737:chemistry* / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D016018:Least-Squares Analysis; D016014:Linear Models; D008956:Models, Chemical; D011899:Ranitidine / Q000737:chemistry; D012995:Solubility / Q000187:drug effects; D013056:Spectrophotometry, Ultraviolet; D013696:Temperature; D013816:Thermodynamics
D000806:Angiotensin-Converting Enzyme Inhibitors; D002021:Buffers; D006635:Histamine H2 Antagonists; D015738:Famotidine; D002927:Cimetidine; D011899:Ranitidine; D017328:Fosinopril